SANNUO 5% Minoxidil Hair Growth Treatment
- Manufacturer
- Shenzhen Baixingchen Technology Co., Ltd.
- Effective date
- 2024-04-24
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 00:11:23
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Minoxidil 5%
OTC - ASK DOCTOR SECTION
Ask a Doctor before use if you
have Heart disease.
WARNINGS SECTION
Warnings
-For external use only.
-Keep away from fire and flame.
-Avoid contact with eyes.
OTC - DO NOT USE SECTION
Do not use
-You have no family history of hair loss,hair loss is sudden and/orpatchy.
-You do not know the reason for your hair loss.
-You are under 18 years of age.
Do not use it on babies and children.
-Your scalp is red,inflamed, infect-edirritated,or painful.
-You use other medicines on the scalp.
OTC - WHEN USING SECTION
When using
-Do not apply on other parts of the body.
-void contact with eyes. In case of accidental contact, rinse eyes with a large amount of cool tap water.
-It takes time to regrow hair. You may need to use this product 2 times a day for a least 4 months before you see results, The amount of hair regrowth is different for each person
OTC - STOP USE SECTION
Stop use and ask doctor if
-chest pain,rapid heart beat,faintness,or dizziness occurs sudden, unexplained weight gain occurs your hands or feet swell scalp irritation or redness occurs
-May be harmful when pregnant or breast-feeding
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep Out of Reach of Children
If swallowed, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
OTC - PURPOSE SECTION
Hair Regrowth Treatment
OTHER SAFETY INFORMATION
Other information
-Before use, read all information on the carton.
-Store at controlled room temperature 20 to 25 ℃ (68 to 77°F)
DOSAGE & ADMINISTRATION SECTION
Directions
-Apply 1ml (7 Sprays) twice a day.
Once in the morning and another time in the evening before bed.
-Spray directly on top of the scalp in the area to be treated.
-Using more than directed or more often will not improve results.
-Continued use is necessary to increase and then maintain your hair regrowth.
-Discontinuing use may result in hair loss.
INACTIVE INGREDIENT SECTION
Inactive ingredients
Propylene Glycol, Ethyl Alcohol, Aqua.
INDICATIONS & USAGE SECTION
Use to regrow hair on the top of the scalp.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| MINOXIDIL Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 83648-003-01 | 2025-07-29 | C162847 | 48780-1 | 3b156c62-24bd-fb37-e063-e6dba90a4e07 | 16dbad79-caea-bdc5-e063-6294a90ac8f7 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83648-003-01 | SANNUO 5% Minoxidil Hair Growth Treatment | 60 mL in 1 BOTTLE | SPRAY | 60 | 2 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- SANNUO 5% Minoxidil Hair Growth Treatment
- Hair Growth Spray
- MINOXIDIL
- WATER
- PROPYLENE GLYCOL
- ALCOHOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 83648-003 | 83648-003-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| MINOXIDIL | 5965120SH1 | ACTIB |
| WATER | 059QF0KO0R | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| ALCOHOL | 3K9958V90M | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 16db9d7e-c2dc-99f0-e063-6394a90a3902 | 16dbad79-caea-bdc5-e063-6294a90ac8f7 | 2024-04-24 | Warnings | 16db9d7e-c2dc-99f0-e063-6394a90a3902 16dbad79-caea-bdc5-e063-6294a90ac8f7 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
